1. XIAP Antagonist Embelin Inhibited Proliferation of Cholangiocarcinoma Cells
   Cody J. Wehrkamp et al, 2014, PLoS ONE CrossRef
2. mRNA Expression of Bax, Bcl-2, p53, Cathepsin B, Caspase-3 and Caspase-9 in the HepG2 Cell Line Following Induction by a Novel Monoclonal Ab Hep88 mAb: Cross-Talk for Paraptosis and Apoptosis
   Thantip Mitupatum et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
3. Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells
   Nupur Nigam et al, 2015, PLOS ONE CrossRef
4. Embelin can protect mice from thioacetamide-induced acute liver injury
   Huafeng Wang et al, 2019, Biomedicine & Pharmacotherapy CrossRef
5. Embelin – a drug of antiquity: shifting the paradigm towards modern medicine
   Radhika Poojari, 2014, Expert Opinion on Investigational Drugs CrossRef
6. Design, synthesis, and SAR of embelin analogues as the inhibitors of PAI-1 (plasminogen activator inhibitor-1)
   Fanglei Chen et al, 2014, Bioorganic & Medicinal Chemistry Letters CrossRef
7. Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone
   null Prashanth N et al, 2024, Science of The Total Environment CrossRef
8. Synthesis and characterization of zinc oxide nanoparticles from Morus nigra and its anticancer activity of AGS gastric cancer cells
   Qing Tang et al, 2020, Journal of Photochemistry and Photobiology B: Biology CrossRef
9. Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases
   Uzini Devi Daimary et al, 2022, Journal of Biochemical and Molecular Toxicology CrossRef
10. Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells
    Kirti S. Prabhu et al, 2017, PLOS ONE CrossRef